Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dee3727dba91e4e7aa3b26ce9efbcc21 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4178 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12 |
filingDate |
2008-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2011-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0475d35fec749192c895f17e3b354b35 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c09862dfc19558de369fe468ceede3b9 |
publicationDate |
2011-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-2176253-B1 |
titleOfInvention |
A process for the preparation or purification of olmesartan medoxomil or olmesartan medoxomil hydrohalide salt |
abstract |
The present invention relates to a process for the preparation and purification of olmesartan medoxomil hydrohalide salts and optionally converting them to olmesartan medoxomil. The invention also relates to products obtainable by the process of the invention, to pharmaceutical compositions comprising the products and to their use in medicine, particularly to treat hypertension. |
priorityDate |
2007-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |